Molecular Pathways and Their Clinical Implications in Ischemic Heart Disease and Heart Failure: From Pathophysiology to Therapeutic Strategies

A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Molecular and Translational Medicine".

Deadline for manuscript submissions: 31 January 2026 | Viewed by 4

Special Issue Editors


E-Mail
Guest Editor
Second Cardiology Department, Medical School, Hippokration General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece
Interests: heart failure; ischemic heart disease; atrial fibrillation; cardiometabolic diseases; precision medicine

E-Mail Website
Guest Editor
1. Second Department of Cardiology, Hippokration General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece
2. Department of Emergency Medicine, AHEPA University Hospital, 54636 Thessaloniki, Greece
Interests: myocardial infarction; heart failure; coronary artery disease; atrial fibrillation; precision medicine
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Ischemic heart disease (IHD) and heart failure (HF) remain leading causes of morbidity and mortality worldwide, despite significant advancements in diagnosis and treatment. Understanding the underlying molecular mechanisms of these conditions is crucial for the development of targeted and effective therapeutic strategies. This Special Issue of Biomedicines aims to explore the latest insights into the molecular characterization of IHD and HF, from pathophysiological mechanisms to novel therapeutic approaches.

We welcome contributions that elucidate the role of inflammation, oxidative stress, mitochondrial dysfunction, and genetic/epigenetic modifications in the progression of IHD and HF. Studies on biomarkers, molecular imaging techniques, and innovative pharmacological or gene-based therapies are particularly encouraged. Additionally, research on personalized and precision medicine approaches for optimizing patient outcomes will be highly relevant.

This Special Issue invites original research articles, reviews, and clinical studies that enhance our understanding of molecular pathways in IHD and HF and pave the way for future translational applications. By bridging the gap between basic science and clinical practice, we aim to foster the development of cutting-edge, patient-centered treatment strategies.

Dr. Panagiotis Stachteas
Dr. Efstratios Karagiannidis
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • ischemic heart disease
  • heart failure
  • molecular mechanisms
  • biomarkers
  • targeted therapy
  • precision medicine

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop